Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$956M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$924M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$769M |
| 4 |
Vanguard Value ETF
VTV
|
+$410M |
| 5 |
Kenvue
KVUE
|
+$393M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$411M |
| 2 |
Johnson & Johnson
JNJ
|
+$234M |
| 3 |
Cisco
CSCO
|
+$181M |
| 4 |
iShares Gold Trust
IAU
|
+$143M |
| 5 |
LSI
Life Storage, Inc.
LSI
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.03% |
| 2 | Healthcare | 12.31% |
| 3 | Financials | 11.79% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Industrials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Newmont
NEM
$96.4B
| $628M | 0.18% |
17,003,452
+483,377
| +3% | +$19.7M |
|
102
ServiceNow
NOW
$114B
| $621M | 0.18% |
5,552,700
+69,085
| +1% | +$7.88M |
|
103
Applied Materials
AMAT
$378B
| $613M | 0.18% |
4,428,005
+5,220
| +0.1% | +$749K |
|
104
Goldman Sachs
GS
$305B
| $598M | 0.17% |
1,848,113
+19,920
| +1% | +$6.66M |
|
105
Intuitive Surgical
ISRG
$130B
| $593M | 0.17% |
2,030,415
+17,477
| +0.9% | +$5.46M |
|
106
NextEra Energy
NEE
$186B
| $593M | 0.17% |
10,352,695
+148,674
| +1% | +$10.3M |
|
107
Deere & Co
DE
$173B
| $581M | 0.17% |
1,539,699
+33,946
| +2% | +$14M |
|
108
Zoetis
ZTS
$32.5B
| $573M | 0.16% |
3,315,133
+3,840
| +0.1% | +$697K |
|
109
Boeing
BA
$175B
| $572M | 0.16% |
2,984,860
-18,361
| -0.6% | -$4.02M |
|
110
TJX Companies
TJX
$178B
| $571M | 0.16% |
6,418,861
+1,910
| +0% | +$168K |
|
111
Citigroup
C
$222B
| $566M | 0.16% |
13,751,201
+192,631
| +1% | +$8.45M |
|
112
Cigna
CI
$79.6B
| $551M | 0.16% |
1,925,051
+30,352
| +2% | +$8.66M |
|
113
Gilead Sciences
GILD
$167B
| $539M | 0.15% |
7,194,007
-58,198
| -0.8% | -$4.48M |
|
114
LyondellBasell Industries
LYB
$18.8B
| $535M | 0.15% |
5,650,680
+143,542
| +3% | +$13.8M |
|
115
JPMorgan Ultra-Short Income ETF
JPST
$40.1B
| $521M | 0.15% |
10,375,719
-62,595
| -0.6% | -$3.14M |
|
116
T. Rowe Price
TROW
$26.1B
| $514M | 0.15% |
4,900,101
+134,839
| +3% | +$15.2M |
|
117
Vertex Pharmaceuticals
VRTX
$124B
| $510M | 0.15% |
1,467,428
+17,564
| +1% | +$6.14M |
|
118
Mondelez International
MDLZ
$80.2B
| $505M | 0.14% |
7,271,547
+69,381
| +1% | +$5M |
|
119
Truist Financial
TFC
$64.7B
| $495M | 0.14% |
17,780,140
+8,567
| +0% | +$263K |
|
120
Regeneron Pharmaceuticals
REGN
$72.9B
| $492M | 0.14% |
598,058
-1,978
| -0.3% | -$1.55M |
|
121
Crown Castle
CCI
$33.1B
| $489M | 0.14% |
5,355,529
+111,209
| +2% | +$11.5M |
|
|
MRSH
122
Marsh
MRSH
$91.7B
| $482M | 0.14% |
2,530,964
+28,013
| +1% | +$5.37M |
|
123
Lam Research
LRCX
$337B
| $478M | 0.14% |
7,628,200
+4,090
| +0.1% | +$269K |
|
124
Watsco Inc
WSO
$15.1B
| $477M | 0.14% |
1,310,201
+9,201
| +0.7% | +$3.33M |
|
125
Stryker
SYK
$133B
| $476M | 0.14% |
1,740,456
+40,736
| +2% | +$11.7M |
|
Similar funds
Charles Schwab's Q3 2023 Portfolio in Review
As of Q3 2023, Charles Schwab held 3,713 positions worth $349B, down 0.3% from $350B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab deployed $12.6B of net new capital in Q3 2023, opening 104 new positions and adding to 2,394 existing holdings. Its largest new stake was Vanguard Value ETF: 2,862,740 shares worth $395M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $234M trimmed.
- Charles Schwab's largest Q3 2023 buy was Vanguard Value ETF: 2,862,740 shares worth $395M.
- Charles Schwab added most to iShares Core US Aggregate Bond ETF in Q3 2023, an estimated $956M increase.
- Charles Schwab's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $234M.
- Charles Schwab fully exited iShares 0-5 Year TIPS Bond ETF in Q3 2023, selling an estimated $411M.
- Charles Schwab's ten largest holdings make up 18% of its $349B portfolio in Q3 2023.
- Charles Schwab opened 104 new positions and closed 137 in Q3 2023.
- Charles Schwab's portfolio value fell 0.3% quarter-over-quarter to $349B.
Based on Charles Schwab's 13F filing for Q3 2023, filed 8 Nov 2023.